Startups

Biomedical research discovery tool.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 60

Locations

Company Size

  • 51 - 101

Last Stage Round

Insights

Causaly, a London-based company, shows significant potential at the intersection of artificial intelligence, biotechnology, and pharmaceuticals. Its SaaS platform accelerates biomedical research by replacing traditional, manual data analysis with advanced AI, streamlining processes and speeding up progress. This advantage is crucial in a field where time-to-discovery impacts patient outcomes and healthcare advancements. Supported by prominent investors, Causaly is well-positioned to meet the growing demand for innovative health tech solutions, making it a strong contender in biomedical research.

Total Funding
$78.2M

Investors

Premium Member Intelligence

    Access details of the company management, and other intelligence on this company via Seedtable Intel